Literature DB >> 22347973

Fatty liver deposition and sparing: a pictorial review.

Patrick-Olivier Décarie, Luigi Lepanto, Jean-Sébastien Billiard, Damien Olivié, Jessica Murphy-Lavallée, Claude Kauffmann, An Tang.   

Abstract

OBJECTIVE: Fatty liver deposition is a very common finding, but it has many atypical patterns of distribution that can represent diagnostic pitfalls. The purpose of this pictorial essay is to review different patterns of fatty liver deposition and sparing.
METHODS: We searched our archive retrospectively, reviewed the literature, and identified six patterns of liver steatosis.
RESULTS: Steatosis may be diffuse, geographic, focal, subcapsular, multifocal or perivascular.
CONCLUSIONS: Previous knowledge of atypical patterns of steatosis distribution may prevent misdiagnosis of infiltrative disease or focal liver lesions. When an unusual form of fatty liver deposition is suspected on ultrasound or computed tomography, magnetic resonance imaging may be used to confirm the diagnosis.

Entities:  

Year:  2011        PMID: 22347973      PMCID: PMC3259375          DOI: 10.1007/s13244-011-0112-5

Source DB:  PubMed          Journal:  Insights Imaging        ISSN: 1869-4101


Introduction

Fatty liver disease is a very common condition, with a prevalence of 20–30% in the adult population [1] and 70% in diabetes patients [2]. Among patients who develop non-alcoholic steatohepatitis (NASH), half will evolve to fibrosis, 10–15% to cirrhosis and 5.4% to hepatic insufficiency [1]. Radiologists must report fatty liver disease because it may have serious long-term consequences if left untreated. Recent trials have shown histological improvements of steatosis and NASH after a medical treatment [3]. Fatty liver may present with different patterns of deposition and sparing. We searched our archive retrospectively, reviewed the literature and identified six patterns of liver steatosis: diffuse, geographic, focal, subcapsular, multifocal and perivascular. Diffuse forms may be graded subjectively according to severity (mild, moderate, severe) or quantitatively with magnetic resonance (MR)-based methods [4]. Some unusual focal forms may be misdiagnosed as infiltrative or nodular liver lesions. Therefore, previous knowledge of their cross-sectional appearance may prevent unwarranted investigations or allow non-invasive diagnosis. Ultrasound is the first-line imaging technique for the screening and follow-up of patients with chronic liver disease. It is, therefore, important for radiologists to be aware of patterns of heterogeneous or focal forms of fatty deposition. On ultrasound, fatty liver is hyperechoic compared with renal cortex and spleen, whereas fatty sparing is isoechoic or hypoechoic. On unenhanced computed tomography (CT), liver density less than 40 Hounsfield units (HU) [5] or a density difference of more than 10 HU between spleen and liver indicates fatty liver [6]. Alternatively, liver parenchyma hypodensity relative to vessels establishes the presence of moderate to severe fatty liver disease [7]. On portal phase contrast-enhanced CT with a standardised protocol, a density difference greater than 25 HU between spleen and liver suggests fatty liver deposition [6]. CT with contrast material was previously thought to be less reliable in detecting fatty liver. However, recent data suggest that portal phase contrast-enhanced CT using blood-subtracted hepatic attenuation may have a similar accuracy to or even greater accuracy than unenhanced CT in the diagnosis of fatty liver [8]. MR imaging (MRI) allows measurement of fat and water proton signals and is considered the most accurate non-invasive technique for hepatic fat quantification [4]. Chemical shift gradient-echo imaging is a widely available MRI technique for fat detection and quantification. Fatty liver shows a signal drop on gradient echo T1-weighted out-of-phase images compared with in-phase images [7]. The dual-echo method results in underestimation of the fat fraction by only 2.9% compared with spectroscopy, the non-invasive “gold standard” [9].

Diffuse fat deposition

Diffuse fatty liver deposition is the most prevalent form of fatty liver disease. The liver is homogeneously involved by fat accumulation (Fig. 1). It may have different levels of severity that can be determined by using quantification maps. The presence of diffuse steatosis in a patient with hepatomegaly and an enlarged caudate-to-right lobe ratio should raise the possibility of NASH [10].
Fig. 1

a–d Severe diffuse fatty liver disease. a Ultrasound image in a 58-year-old man known for intraductal papillary mucinous neoplasm (IPMN/IPMT) of the pancreas and alcoholic pancreatitis showing a hyperechoic liver compared with the right renal cortex. b CT, axial contrast-enhanced portal phase image shows a diffusely hypodense liver (42 HU) compared with the spleen (113 HU) (>25 HU difference). MRI, c axial T1-weighted in-phase and d out-of-phase images show an important signal drop of the liver on the opposed-phase image. MR images were obtained on a 1.5-T MRI system with TEs of 2.2 and 4.5 for in- and out-of-phase images respectively

a–d Severe diffuse fatty liver disease. a Ultrasound image in a 58-year-old man known for intraductal papillary mucinous neoplasm (IPMN/IPMT) of the pancreas and alcoholic pancreatitis showing a hyperechoic liver compared with the right renal cortex. b CT, axial contrast-enhanced portal phase image shows a diffusely hypodense liver (42 HU) compared with the spleen (113 HU) (>25 HU difference). MRI, c axial T1-weighted in-phase and d out-of-phase images show an important signal drop of the liver on the opposed-phase image. MR images were obtained on a 1.5-T MRI system with TEs of 2.2 and 4.5 for in- and out-of-phase images respectively

Geographic fat deposition

Geographic fatty liver disease is a frequently encountered variant. Different geographic patterns can be attributed to specific causes. For example, fat accumulation sometimes occurs only in the right lobe (Fig. 2). One hypothesis to explain this distribution is that blood from the superior mesenteric vein containing lipogenic alimentary factors is preferentially distributed to the right lobe of the liver [11]. Geographic patterns may be secondary to an insult to the liver parenchyma. For example, fatty liver deposition can be distributed in territories previously affected by cholangitis (Fig. 3).
Fig. 2

a, bGeographic fat accumulation limited to the right lobe of the liver. MRI of the liver in a 57-year-old woman known for multiple focal nodular hyperplasia. a Axial T1-weighted in-phase and b out-of-phase images show an important signal drop in the right lobe of the liver on opposed-phase image

Fig. 3

a–c Severe geographic fatty liver deposition. MRI of the liver in a 76-year-old man who had hepatico-jejunostomy for biliary duct trauma and stenosis followed by two episodes of cholangitis in 1997 and 2006. a Axial T1-weighted in-phase and b out-of-phase images show an important signal drop on the opposed-phase image in a geographic distribution, affecting the hepatic dome more severely. c Subtraction confirms severe geographic fatty liver deposition

a, bGeographic fat accumulation limited to the right lobe of the liver. MRI of the liver in a 57-year-old woman known for multiple focal nodular hyperplasia. a Axial T1-weighted in-phase and b out-of-phase images show an important signal drop in the right lobe of the liver on opposed-phase image a–c Severe geographic fatty liver deposition. MRI of the liver in a 76-year-old man who had hepatico-jejunostomy for biliary duct trauma and stenosis followed by two episodes of cholangitis in 1997 and 2006. a Axial T1-weighted in-phase and b out-of-phase images show an important signal drop on the opposed-phase image in a geographic distribution, affecting the hepatic dome more severely. c Subtraction confirms severe geographic fatty liver deposition

Focal fat deposition and focal fatty sparing

Focal fat deposition is slightly less common and can mimic other hepatic benign or malignant lesions on ultrasound and CT (Fig. 4). MRI is very useful for making the diagnosis of focal hepatic steatosis, which appears isointense or hyperintense to liver on in-phase images and loses signal on out-of-phase images. Fat accumulation does not show diffusion restriction, which may also be useful to differentiate steatosis from other liver abnormalities. Moreover, focal fat accumulation tends to show wedge–shaped margins, no mass effect on adjacent blood vessels or the biliary tree, sharp boundaries, and lobar or segmental distribution [12].
Fig. 4

Focal fatty liver deposition. a CT, axial contrast-enhanced portal phase image in a 58-year-old woman shows a hypodense, mildly heterogeneous, cuneiform lesion in the posterior aspect of segment IV. MRI, b axial T1-weighted in-phase and c out-of-phase images show a signal drop within this lesion on the opposed-phase image

Focal fatty liver deposition. a CT, axial contrast-enhanced portal phase image in a 58-year-old woman shows a hypodense, mildly heterogeneous, cuneiform lesion in the posterior aspect of segment IV. MRI, b axial T1-weighted in-phase and c out-of-phase images show a signal drop within this lesion on the opposed-phase image Some regions of the liver are more prone to being affected by focal fat deposition. The same regions correspond to spared areas in diffuse fat deposition (Fig. 5). Those are the perivesicular and subcapsular regions abutting the hepatic hilum or falciform ligament in the area drained by the Sapey’s vein [7, 11]. The classical patterns of focal fatty liver deposition and sparing are linked to vascular anatomical variants that involve capsular veins, peribiliary veins, the cystic vein (which drains perivesicular areas), and the right gastric vein (which drains the anterior portion of segment I and the posterior portion of segment IV). These veins can be the source of an aberrant venous draining system without portal inflow causing local haemodynamic anomalies that may lead to focal fatty liver deposition and sparing [11, 13].
Fig. 5

a–d Perivesicular fatty sparing. a Ultrasound image in a 77-year-old woman who had nephrectomy for renal cell carcinoma shows a hyperechoic liver with hypoechoic perivesicular foci. b CT, axial contrast-enhanced portal phase image shows a diffusely hypodense liver (57 HU) in comparison with the spleen (135 HU) with a perivesicular spared zone (in segments IV and V). MRI, c axial T1-weighted in-phase and d out-of-phase images show an important signal drop of the liver on the opposed-phase image with the exception of a perivesicular spared zone

a–d Perivesicular fatty sparing. a Ultrasound image in a 77-year-old woman who had nephrectomy for renal cell carcinoma shows a hyperechoic liver with hypoechoic perivesicular foci. b CT, axial contrast-enhanced portal phase image shows a diffusely hypodense liver (57 HU) in comparison with the spleen (135 HU) with a perivesicular spared zone (in segments IV and V). MRI, c axial T1-weighted in-phase and d out-of-phase images show an important signal drop of the liver on the opposed-phase image with the exception of a perivesicular spared zone

Subcapsular fat deposition

Subcapsular fat deposition may present as small fat nodules (Fig. 6) or as a confluent peripheral region of fat confined to a subcapsular zone [7]. It may be caused by insulin added to the peritoneal dialysate in certain patients with renal failure and insulin-dependent diabetes. Subcapsular hepatocytes are exposed to a higher concentration of insulin than the rest of the liver in those patients. Because insulin promotes the esterification of free fatty acids into triglycerides, the peritoneal administration of insulin can result in subcapsular fat accumulation [14]. This form of fatty liver deposition may also be idiopathic.
Fig. 6

a–c Subcapsular fatty liver deposition. a Axial contrast-enhanced portal phase CT image in a 58-year-old man with a neuro-endocrine tumour of the pancreas shows two small hypodense subcapsular hepatic lesions in segment V. MRI, b axial T1-weighted in-phase and c out-of-phase images show a drop of signal within the two subcapsular lesions on the opposed-phase image

a–c Subcapsular fatty liver deposition. a Axial contrast-enhanced portal phase CT image in a 58-year-old man with a neuro-endocrine tumour of the pancreas shows two small hypodense subcapsular hepatic lesions in segment V. MRI, b axial T1-weighted in-phase and c out-of-phase images show a drop of signal within the two subcapsular lesions on the opposed-phase image

Multifocal fat deposition

Multifocal fatty liver deposition is another unusual pattern that can represent a difficult diagnostic challenge. This entity has also been described as multinodular hepatic steatosis [15]. Multiple fat foci are randomly distributed throughout the liver. The foci are usually round or oval and may mimic multiple nodules. The differential diagnosis on CT and ultrasound may include metastasis, lymphoma, sarcoidosis, abscesses, candidiasis, haemangiomatosis and biliary hamartomas. MRI is usually required to make the diagnosis (Fig. 7). The pathogenesis of multifocal fat deposition is unknown.
Fig. 7

a–d Multifocal fatty liver deposition. a Ultrasound image in a 39-year-old woman with lymphoma and malignant thymoma with local pleural recurrence treated with radiotherapy and chemotherapy shows multiple nodular hyperechoic foci throughout the liver. b CT, axial unenhanced image shows multiple hypodense foci throughout the liver. MRI, c axial T1-weighted in-phase and d out-of-phase images show multiple lesions with signal drop on the opposed-phase image

a–d Multifocal fatty liver deposition. a Ultrasound image in a 39-year-old woman with lymphoma and malignant thymoma with local pleural recurrence treated with radiotherapy and chemotherapy shows multiple nodular hyperechoic foci throughout the liver. b CT, axial unenhanced image shows multiple hypodense foci throughout the liver. MRI, c axial T1-weighted in-phase and d out-of-phase images show multiple lesions with signal drop on the opposed-phase image

Perivascular fat deposition and perivascular fatty sparing

A very unusual pattern of fatty liver disease is perivascular deposition. Halos of fat surround the hepatic veins, the portal veins, or both hepatic and portal veins [7]. Perivascular fatty sparing can also be seen (Fig. 8). It may be difficult to differentiate perivascular fat deposition or perivascular sparing from periportal oedema, passive hepatic congestion and Budd–Chiari syndrome on CT and ultrasound. MRI is useful for making this rare diagnosis by showing a signal intensity loss on opposed-phase images compared with in-phase images. The pathogenesis of perivascular fat deposition and sparing is unknown.
Fig. 8

a, b Perivascular fatty sparing. a Ultrasound image in a 39-year-old man with a clinical suspicion of non-alcoholic fatty liver disease based on elevated liver enzymes shows a geographic area of fatty sparing parallel to the right hepatic vein. b Doppler image shows an absence of mass effect on the right hepatic vein

a, b Perivascular fatty sparing. a Ultrasound image in a 39-year-old man with a clinical suspicion of non-alcoholic fatty liver disease based on elevated liver enzymes shows a geographic area of fatty sparing parallel to the right hepatic vein. b Doppler image shows an absence of mass effect on the right hepatic vein

Conclusion

Fatty liver deposition is a very common finding but it has many atypical patterns of distribution that can represent diagnostic pitfalls. Steatosis may be diffuse, geographic, focal, subcapsular, multifocal or perivascular. When an atypical form of fatty liver deposition is suspected on ultrasound or CT, MRI may be used to confirm the diagnosis because of its ability to break down fat and water signal components.
  15 in total

Review 1.  [Hepatic pseudolesions].

Authors:  D Mathieu; A Luciani; A Achab; B Zegai; M Bouanane; H Kobeiter
Journal:  Gastroenterol Clin Biol       Date:  2001-04

2.  Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT.

Authors:  Cody J Boyce; Perry J Pickhardt; David H Kim; Andrew J Taylor; Thomas C Winter; Richard J Bruce; Mary J Lindstrom; J Louis Hinshaw
Journal:  AJR Am J Roentgenol       Date:  2010-03       Impact factor: 3.959

3.  Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation.

Authors:  M Raquel Oliva; Koenraad J Mortele; Enrika Segatto; Jonathan N Glickman; Sukru Mehmet Erturk; Pablo R Ros; Stuart G Silverman
Journal:  J Comput Assist Tomogr       Date:  2006 Jan-Feb       Impact factor: 1.826

Review 4.  Fat-containing lesions of the liver: radiologic-pathologic correlation.

Authors:  Srinivasa R Prasad; Hanlin Wang; Humberto Rosas; Christine O Menias; Vamsi R Narra; William D Middleton; Jay P Heiken
Journal:  Radiographics       Date:  2005 Mar-Apr       Impact factor: 5.333

5.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Naga Chalasani; Kris V Kowdley; Arthur McCullough; Anna Mae Diehl; Nathan M Bass; Brent A Neuschwander-Tetri; Joel E Lavine; James Tonascia; Aynur Unalp; Mark Van Natta; Jeanne Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  N Engl J Med       Date:  2010-04-28       Impact factor: 91.245

Review 6.  Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.

Authors:  David Preiss; Naveed Sattar
Journal:  Clin Sci (Lond)       Date:  2008-09       Impact factor: 6.124

7.  Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage.

Authors:  O Matsui; M Kadoya; S Takahashi; J Yoshikawa; T Gabata; T Takashima; K Kitagawa
Journal:  AJR Am J Roentgenol       Date:  1995-05       Impact factor: 3.959

8.  Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.

Authors:  Takeshi Yokoo; Mark Bydder; Gavin Hamilton; Michael S Middleton; Anthony C Gamst; Tanya Wolfson; Tarek Hassanein; Heather M Patton; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2009-02-12       Impact factor: 11.105

9.  Hepatic subcapsular steatosis in response to intraperitoneal insulin delivery: CT findings and prevalence.

Authors:  Korosh Khalili; Frederick P Lan; Anthony E Hanbidge; Derek Muradali; Dmitrios G Oreopoulos; Ian R Wanless
Journal:  AJR Am J Roentgenol       Date:  2003-06       Impact factor: 3.959

10.  Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard.

Authors:  Dae Yoon Kim; Seong Ho Park; Seung Soo Lee; Hye Jin Kim; So Yeon Kim; Min-Young Kim; Yedaun Lee; Tae Kyoung Kim; Korosh Khalili; Mi Hyun Bae; Joo Yeon Lee; Sung-Gyu Lee; Eun Sil Yu
Journal:  Eur Radiol       Date:  2009-09-02       Impact factor: 5.315

View more
  17 in total

Review 1.  Paediatric liver ultrasound: a pictorial essay.

Authors:  Marco Di Serafino; Rosa Severino; Matilde Gioioso; Eugenio Rossi; Norberto Vezzali; Piernicola Pelliccia; Maria Grazia Caprio; Ciro Acampora; Raffaele Iorio; Gianfrancio Vallone
Journal:  J Ultrasound       Date:  2019-02-18

Review 2.  Paediatric gastrointestinal and hepatobiliary radiology: why do we need subspecialists, and what is new?

Authors:  Tom A Watson; Joy Barber; Helen Woodley
Journal:  Pediatr Radiol       Date:  2021-03-20

3.  Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?

Authors:  Georgia Keramida; Sabina Dizdarevic; Janice Bush; A Michael Peters
Journal:  Eur Radiol       Date:  2015-04-22       Impact factor: 5.315

4.  New exponential functions based on CT density to estimate the percentage of liver that is fat.

Authors:  Georgia Keramida; A Michael Peters
Journal:  Br J Radiol       Date:  2017-05-25       Impact factor: 3.039

Review 5.  Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.

Authors:  Matteo Renzulli; Nicolò Brandi; Giulia Argalia; Stefano Brocchi; Andrea Farolfi; Stefano Fanti; Rita Golfieri
Journal:  Radiol Med       Date:  2022-01-13       Impact factor: 3.469

6.  Algorithm-based approach to focal liver lesions in contrast-enhanced ultrasound.

Authors:  Kheng Song Leow; Christine Ying Kwok; Hsien Min Low; Rahul Lohan; Tze Chwan Lim; Su Chong Albert Low; Cher Heng Tan
Journal:  Australas J Ultrasound Med       Date:  2022-07-04

7.  Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology.

Authors:  Bo-Kyeong Kang; Mimi Kim; Soon-Young Song; Dae Won Jun; Kiseok Jang
Journal:  Br J Radiol       Date:  2017-11-08       Impact factor: 3.039

8.  Tumor-Like Liver Abscess Mimicking Malignancy With Lung Metastases in a Patient With Acute Renal Failure: A Case Report.

Authors:  Chih Hsin Wang; Cheuk-Kay Sun; Jiunn-Song Jiang; Ming Hsien Tsai
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  Multifocal Nodular Fatty Infiltration of the Liver: A Case Report of a Challenging Diagnostic Problem.

Authors:  Giovanni Domenico Tebala; Anees Jwad; Abdul Quyyum Khan; Ervine Long; Guy Sissons
Journal:  Am J Case Rep       Date:  2016-03-27

10.  Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure.

Authors:  Filippo Valbusa; Stefano Bonapace; Cristina Grillo; Luca Scala; Andrea Chiampan; Andrea Rossi; Giacomo Zoppini; Amedeo Lonardo; Guido Arcaro; Christopher D Byrne; Giovanni Targher
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.